MCL1 and Miyoshi myopathy: Inhibition of glucose metabolism with the GLUT4 inhibitor ritonavir blocks proliferation in MM and induces apoptosis by reducing MCL-1 levels that is enhanced with venetoclax, suggesting that nutrient deprivation may re-configure BCL-2 family protein dependence in MM cells and enable sensitization to venetoclax119.